Skip to main content

Table 2 Mean pre-, post-, six to nine month follow-up scores of GP awareness, practice, knowledge, confidence

From: GP awareness, practice, knowledge and confidence: evaluation of the first nation-wide dementia-focused continuing medical education program in Australia

 Pre-CMEa program score, Mean (SD)bPost-program score, Mean (SD)Six to nine month follow-up score, Mean (SD)
Face-to-faceOnlineTotalFace-to-faceOnlineTotalFace-to-faceOnlineTotal
Awareness topics (range − 2 to 2)c, d(n = 698–711)(n = 591)(n = 1289–1302)(n = 652–661)(n = 356)(n = 1008–1017)(n = 86–88)(n = 50–51)(n = 136–139)
1.1 Early warning signs for dementia0.7 (0.8)0.9 (0.8)0.8 (0.8)1.5 (0.5)1.5 (0.6)1.5 (0.6)1.3 (0.5)1.4 (0.5)1.3 (0.5)
1.2 Different types of dementia0.8 (0.8)0.9 (0.9)0.8 (0.8)1.5 (0.5)1.6 (0.6)1.5 (0.6)1.2 (0.6)1.3 (0.6)1.2 (0.6)
1.3 Difference between Mild Cognitive Impairment (MCI) and dementia−0.3 (1.1)0.5 (1.1)0.1 (1.2)1.5 (0.6)1.5 (0.6)1.5 (0.6)0.8 (1.0)1.1 (0.9)0.9 (0.9)
1.4 Barriers to diagnosis0.4 (1.0)0.8 (0.9)0.6 (1.0)1.4 (0.6)1.4 (0.6)1.4 (0.6)1.2 (0.6)1.3 (0.6)1.2 (0.6)
1.5 Consequences of not recognizing dementia0.6 (1.0)1.0 (0.8)0.8 (0.9)1.4 (0.6)1.5 (0.7)1.4 (0.6)1.4 (0.6)1.5 (0.6)1.4 (0.6)
1.6 Impact of co-morbidities on dementia diagnosis0.5 (1.0)1.0 (0.9)0.7 (1.0)1.4 (0.6)1.5 (0.6)1.4 (0.6)1.4 (0.6)1.4 (0.6)1.4 (0.6)
1.7 Behavioral and psychological symptoms of dementia (BPSD)0.6 (0.9)0.9 (0.9)0.7 (0.9)1.5 (0.6)1.5 (0.6)1.5 (0.6)1.3 (0.5)1.4 (0.5)1.3 (0.5)
1.8 Caregiver management education, support and referral0.01 (1.1)0.8 (1.0)0.4 (1.1)1.3 (0.7)1.5 (0.6)1.4 (0.7)1.2 (0.7)1.2 (0.7)1.2 (0.7)
1.9 Legal issues and dementia−0.01 (1.1)0.8 (1.0)0.3 (1.1)1.3 (0.6)1.5 (0.6)1.4 (0.6)1.0 (0.7)1.2 (0.4)1.1 (0.6)
1.10 Non-pharmacological management methods for BPSD0.1 (1.1)0.7 (1.0)0.4 (1.1)1.3 (0.7)1.4 (0.6)1.4 (0.7)1.1 (0.7)1.3 (0.6)1.2 (0.6)
1.11 Pharmacological management methods for BPSD0.1 (1.1)0.7 (1.0)0.4 (1.1)1.3 (0.7)1.4 (0.7)1.4 (0.7)1.1 (0.6)1.3 (0.6)1.1 (0.6)
1.12 Use of acetylcholinesterase inhibitors (AChEI) for the management of patients with dementia0.3 (1.0)0.7 (1.0)0.5 (1.0)1.3 (0.6)1.4 (0.7)1.4 (0.6)1.1 (0.5)1.0 (0.7)1.1 (0.6)
1.13 The cumulative anticholinergic effect of medications which can negatively affect cognition in all people especially the elderly−0.01 (1.7)0.7 (1.0)0.3 (1.4)1.4 (0.7)1.4 (0.7)1.4 (0.7)1.3 (0.6)1.1 (0.7)1.2 (0.7)
1.14 The fact that people with dementia are particularly sensitive to adverse effects of medications on cognition such as anticholinergics and sedatives0.4 (1.1)0.9 (0.9)0.6 (1.0)1.5 (0.6)1.5 (0.6)1.5 (0.6)1.5 (0.6)1.2 (0.7)1.4 (0.6)
1.15 The importance of diagnosis and management of dementia in my practice0.9 (0.9)1.1 (0.9)1.0 (0.9)1.5 (0.5)1.6 (0.6)1.6 (0.6)1.7 (0.5)1.4 (0.6)1.6 (0.5)
 Face-to-faceOnlineTotalFace-to-faceOnlineTotalFace-to-faceOnlineTotal
Practice topics (range 0–4)e, f(n = 693–703)(n = 591)(n = 1284–1294)(n = 650–658)(n = 356)(n = 1006–1014)(n = 86–87)(n = 47–49)(n = 134–136)
2.1 Use assessment tools to help diagnose dementia2.3 (1.2)2.4 (1.1)2.4 (1.1)3.5 (0.6)3.4 (0.7)3.5 (0.7)3.1 (0.7)3.1 (0.8)3.1 (0.8)
2.2 Use pharmacological management methods for BPSD1.5 (1.0)1.8 (1.0)1.6 (1.0)2.5 (1.0)2.8 (0.9)2.6 (1.0)2.0 (0.8)2.3 (0.9)2.1 (0.8)
2.3 Use non-pharmacological management methods for BPSD1.9 (1.1)2.1 (1.0)2.0 (1.0)3.4 (0.7)3.3 (0.7)3.4 (0.7)2.8 (0.8)2.8 (0.8)2.8 (0.8)
2.4 Refer patients to Alzheimer‘s Australiag1.5 (1.2)2.0 (1.2)1.7 (1.2)3.4 (0.8)3.4 (0.8)3.4 (0.8)2.5 (1.1)2.7 (1.1)2.6 (1.1)
2.5 Assess caregiver stress2.4 (1.0)2.5 (1.0)2.4 (1.0)3.6 (0.6)3.5 (0.7)3.5 (0.6)3.2 (0.8)3.2 (0.8)3.2 (0.8)
2.6 Refer caregivers for counselling1.8 (1.0)2.1 (1.1)1.9 (1.1)3.2 (0.8)3.3 (0.8)3.2 (0.8)2.4 (0.9)2.4 (1.2)2.4 (1.0)
2.7 Counsel patients and their families about legal issues1.8 (1.1)2.3 (1.1)2.0 (1.1)3.5 (0.7)3.5 (0.7)3.5 (0.7)2.8 (0.9)1.0 (1.0)2.8 (1.0)
2.8 Consider the safety of my patient with dementia to drive2.8 (1.1)1.0 (1.0)2.9 (1.0)3.7 (0.5)3.6 (0.6)3.7 (0.6)3.6 (0.6)3.6 (0.7)3.6 (0.6)
 Face-to-faceOnlineTotalFace-to-faceOnlineTotalFace-to-faceOnlineTotal
Self-perceived level of Knowledge and Confidence (range 0–10)h(n = 711)(n = 591)(n = 1302)(n = 660)(n = 356)(n = 1016)(n = 88)(n = 49)(n = 137)
Knowledge5.0 (1.6)5.2 (2.0)5.1 (1.8)7.1 (1.2)7.6 (1.1)7.3 (1.2)7.0 (1.1)7.3 (1.2)7.1 (1.1)
Confidence5.1 (1.8)i5.2 (1.9)5.1 (1.9)j7.1 (1.3)7.7 (1.2)7.3 (1.3)7.3 (1.3)7.6 (1.2)7.4 (1.3)
  1. aCME, Continuing Medical Education
  2. bSD, Standard deviation
  3. cAwareness pre-education question-prompt “Prior to attending this workshop I was aware of …”; Post-education question-prompt “Now that I have completed this training I am aware of …”; and Follow-up question-prompt “Currently I am aware of …”
  4. dValue index for awareness-related items: Disagree strongly = − 2, Disagree = − 1, Agree = 1, Agree strongly = 2
  5. ePractice Pre-education question-prompt “I currently …”; Post-education question-prompt “Now that I have completed this training I plan to …”; and Follow-up question-prompt “In my practice currently I …”
  6. fValue for index for practice-related items: Never = 0, Rarely = 1, Half the time = 2, Usually = 3, Always = 4
  7. gNow Dementia Australia
  8. hLikert scale for Knowledge and Confidence: 0–10
  9. in = 710
  10. jn = 1301